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ABSTRACT: Three (nor)illudalane sesquiterpenes were synthesized from a common intermediate in racemic and
enantioenriched forms using Pd0-catalyzed C(sp3)−H arylation as a key step. The configuration of the isolated, highly
symmetric quaternary stereocenter of the target molecules was controlled through a matched combination of chiral substrate
and catalyst. Moreover, the recently developed Ir-catalyzed C−H borylation/Cu-catalyzed methylation method was employed
to install the methyl group on the benzene ring. This strategy allowed the efficient synthesis of both racemic and (S)-configured
puraquinonic acid, deliquinone, and russujaponol F.
■ INTRODUCTION
Illudalane and norilludalane sesquiterpenes are a large family of
bioactive natural products isolated from mycelial cultures of
woody mushrooms.1 These compounds usually contain a
geminal dimethyl group on a cyclopentane ring fused with
diverse scaffolds (Figure 1a). However, some members of this
family possess a quaternary stereocenter, resulting from the
oxidation of one of the geminal methyl groups to a
hydroxymethyl or a carboxylic acid group, such as the
benzoquinones puraquinonic acid (4)2 and deliquinone (5),3
and the indane russujaponol F (6)4 (Figure 1b). The former,
isolated from cultures of Mycena pura, showed a mild
differentiation-inducing activity toward HL-60 cells.2
In addition to a polysubstituted aromatic or benzoquinone
core, the most intriguing part of molecules 4−6 is probably the
highly symmetric quaternary stereocenter resulting from
different substituents three or four carbons away (Figure
1b). Such quaternary stereocenters constitute an interesting
challenge in organic synthesis.5 Indeed, despite a moderate
structural complexity, only two enantioselective syntheses of
puraquinonic acid have been reported before our work,6,7 and
none for russujaponol F and deliquinone. Clive and co-workers
reported the first synthesis of (S)-puraquinonic acid in 31 steps
using an Evans aldol reaction as the enantio-determining step
(Scheme 1a, 8→ 9).6c,d This strategy required a large number
of functional group interconversions and manipulations. In
addition, this work established the absolute configuration of
natural puraquinonic acid as (R) upon comparison with a
natural sample. More recently, Gleason and co-workers
disclosed a much more efficient synthesis of (R)-puraquinonic
acid (Scheme 1b).7 The quaternary stereocenter was
constructed at the beginning of the synthesis via sequential
diastereoselective alkylations using a valine-derived chiral
auxiliary (11). Then, the indane core was built using an
elegant and effective combination of enyne metathesis and
Diels−Alder cycloaddition, followed by oxidation with DDQ in
a one-pot procedure (12 → 13). After functional group
manipulations, cleavage of the chiral auxiliary and oxidation of
the aromatic ring to the benzoquinone, this approach yielded
enantiopure (R)-puraquinonic acid in 12 steps and 20% overall
yield from the in-house auxiliary,8 or 15 steps and 14% from
(S)-valinol.
Figure 1. (a) Examples of (nor)illudalanes with a gem-dimethyl
group. (b) (Nor)illudalane targets featuring a highly symmetric
quaternary stereocenter.
In light of our longstanding interest in this field,9 we
considered a different approach to access these molecules,
using Pd0-catalyzed C(sp3)−H activation as the key step
(Scheme 2a). Our retrosynthetic analysis is based on a
disconnection at one of the two C(sp2)−C(sp3) bonds of the
indane 14, which would be constructed via asymmetric
C(sp3)−H arylation.10 The quaternary stereocenter would
arise from the desymmetrization of the two enantiotopic
methyl groups in 15 or 16.
Previously, we reported the synthesis of enantioenriched
indanes using C(sp3)−H arylation in the presence of a chiral
binepine ligand L1 (Scheme 2b).11 In this case, a quaternary
stereocenter was generated via desymmetrization of two
isopropyl groups. More recently, we achieved the generation
of tetrasubstituted stereocenters in the context of indoline
synthesis using a chiral phosphate catalyst.12 In this case, the
stereocenter arose from the desymmetrization of two methyl
groups on a tetrasubstituted carbon (Scheme 2c), which
proved to be more challenging than desymmetrizing methyl
groups on a trisubstituted carbon.13 Moreover, in both
examples the intramolecular C−H arylation was likely favored
by strong Thorpe−Ingold effects. These precedents suggested
that the asymmetric C(sp3)−H arylation of substrates 15 and
16 leading to the formation of the all-carbon stereocenter in 14
would be particularly challenging. Herein, we report our efforts
to synthesize target molecules 1−3 in racemic and
enantioselective manner.14
■ RESULTS AND DISCUSSION
Racemic Synthesis: First Route. We first explored the
feasibility of our strategy with the synthesis of racemic
puraquinonic acid. Our synthetic plan was inspired from
previous work by Kraus and co-workers on the synthesis of
(±)-puraquinonic acid ethyl ester (24) (Scheme 3) and
(±)-deliquinone.15 They prepared the indane ethyl ester 22,
analogous to our putative C−H activation product 14, through
a four-step sequence from 2,3-dimethylanisole. Hence, we
initially intended to follow the same sequence to complete our
total synthesis. From 22, the phenol methyl group was
replaced with an allyl group, and an aromatic Claisen
rearrangement led to compound 23. The terminal alkene was
cleaved via reductive ozonolysis to give the corresponding
alcohol, and the phenol was oxidized to the corresponding
benzoquinone in the presence of salcomine and oxygen.
Finally, the missing methyl group was introduced by radical
methylation using acetic acid and silver nitrate. Of note, Kraus
Scheme 1. Previous Enantioselective Total Syntheses of Puraquinonic Acid
Scheme 2. Retrosynthetic Analysis and Previous Work on
the Generation of Tetrasubstituted Stereocenters via Pd0-
Catalyzed C(sp3)−H Activation
and co-workers did not report the saponification of 24 to
puraquinonic acid.
We selected aryl bromide 28 to test conditions for the key
C(sp3)−H arylation (Scheme 4). It was readily prepared by
alkylation of the lithium enolate of methyl isobutyrate with 2-
bromobenzyl bromide. After some optimization, we obtained
the best results using IBioxMe4 (L
2), an N-heterocyclic
carbene (NHC) ligand developed by Glorius and co-
workers,16 which provided a full conversion and ca. 95% of
product (Table 1, entry 1).
Then, we synthesized aryl bromide 15 from 3-bromo-2-
methylphenol 25 (Scheme 4). The latter is commercially
available, but can be prepared on a large scale via Sandmeyer
reaction from 3-bromo-2-methylaniline.17 Phenol 25 was then
methylated with K2CO3 and methyl iodide to yield the
corresponding anisole. The benzylic position was brominated,
and the corresponding benzyl bromide was employed in the
alkylation of the lithium enolate of methyl isobutyrate, in a
similar fashion to 28. This robust sequence led to substrate 15
in 75% overall yield and with only one column chromatog-
raphy. Substrate 16 was prepared in a similar manner from
commercial 2-bromo-1-methoxy-3-methylbenzene 26. Both
substrates were engaged in C(sp3)−H activation under the
same conditions as above. Compound 15 reacted cleanly and
the indane product 14 was isolated in 92% yield (Table 1,
entry 2). In contrast, the isomer 16 gave a very low conversion,
and ca. 90% of the starting material was recovered (entry 3).
The lack of reactivity of 16 can be explained by the sterically
difficult oxidative addition of the di-ortho-substituted bromide
to palladium(0).
Then, we continued our synthesis as initially planned
(Scheme 5). The two methoxy groups of indane 14 were
cleaved using hydrobromic acid in refluxing acetic acid to
obtain the corresponding phenol-carboxylic acid. The crude
mixture was alkylated with KHCO3/MeI and NaH/allyl
bromide in a one-pot fashion18 to give compound 30 in 82%
yield over 2 steps. The latter was engaged in the aromatic
Claisen rearrangement. After screening a few solvents, the best
yield (90%) was achieved with N,N-diethylaniline at 200 °C.
At this stage, we encountered reproducibility issues in the
ozonolysis of 31, with low yields (ca. 20%) and starting
material decomposition. We assume that the free phenol
undergoes oxidation to the benzoquinone and further
degradation. This ozonolysis problem was already observed
Scheme 3. Total Synthesis of Puraquinonic Acid Ethyl Ester
by Kraus
Scheme 4. Preparation of C−H Arylation Substratesa
aReagents and conditions: (a) K2CO3, MeI, DMF, 50 °C; (b) NBS,
(BzO)2, CCl4, reflux; (c)
iPrCO2Me, LDA, 0 °C, then benzyl
bromide, 0 → 25 °C.
Table 1. C(sp3)−H Arylation of Substrates 15, 16, and 28
entry reactant product conv. (%)a,b
1 28 29 95
2 15 14 96 (92)
3 16 14 6
aConversion of the aryl bromide to the indane product estimated by
GC−MS analysis. bYield of isolated product in parentheses.
Scheme 5. First Route for the Synthesis of
(±)-Puraquinonic Acida
aReagents and conditions: (a) HBr aq., AcOH, reflux; (b) KHCO3,
MeI, DMF, 40 °C, then NaH, allyl bromide; (c) PhNEt2, 200 °C; (d)
OsO4 (5 mol %), NaIO4, AcOEt/H2O, 25 °C; (e) NaBH4, MeOH, 0
°C; (f) salcomine hydrate, O2 atm., MeCN, 25 °C; (g) AcOH,
AgNO3, (NH4)2S2O8, MeCN/H2O, 70 °C.
by Clive and co-workers on a similar intermediate, and they
found that the Lemieux−Johnson oxidation gave better
results.6a Accordingly, 31 was oxidized to the corresponding
aldehyde using OsO4 and sodium periodate, and further
reduced with sodium borohydride. This two-step sequence
afforded the corresponding primary alcohol in 87% yield.
Then, the phenol was oxidized to the corresponding
benzoquinone using the same conditions as Kraus and co-
workers,15 i.e., with 40 mol % of salcomine under an oxygen
atmosphere, hence furnishing the unstable benzoquinone 32 in
82% yield.
Unfortunately, the radical methylation of 3215,19 gave
irreproducible yields in the range of 15−55%. We anyway
isolated some methylated benzoquinone 33 and attempted its
saponification. Unfortunately, we never succeeded to isolate
puraquinonic acid despite numerous attempts, due to the
sensitivity of the benzoquinone ring, and hence we decided to
opt for a different strategy. Nevertheless, these results gave us
important information to design a more effective plan. Indeed,
we encountered three major problems during this synthesis:
(1) instability of benzoquinone intermediates; (2) low yield
and irreproducibility of the radical methylation; (3) impossi-
bility to hydrolyze the ester on the benzoquinone. These
problems led us to conclude that the saponification has to be
performed prior to the oxidation to benzoquinone. This also
precludes the introduction of the methyl group via radical
methylation, which would be likely incompatible with the
carboxylic acid moiety. Therefore, this methyl group has to be
installed earlier in the synthesis. Besides, a late-stage oxidation
of the phenol to the benzoquinone would be more adapted in
light of stability issues.
Racemic Synthesis: Second Route. For this second
route, we decided to start with the methyl group already
present at the beginning. The global strategy remains
unchanged until the end, where the ester would be cleaved
first, followed by phenol oxidation to benzoquinone. This new
synthetic plan led us to consider the possibility of preparing
two other natural products, deliquinone and russujaponol F.
Indeed, a common indane intermediate (40, see Scheme 7),
would be the divergent point to prepare these three natural
products.
Compound 36 was first prepared from 2,5-xylenol 34
(Scheme 6, top). The phenol was perbrominated using
bromine and aluminum tribromide, followed by selective
debromination with hydroiodic acid and phenol methylation
with K2CO3 and MeI as described.
20 This sequence yielded the
anisole 35 in 76% overall yield with one distillation as the only
purification. Then selective radical benzylic bromination,21 and
enolate alkylation furnished 36 in 75% yield over two steps and
57% over 5 steps from phenol 34. We envisaged another
strategy to prepare the same benzyl bromide intermediate via
directed lithiation of aryl bromide 37 and formylation to give
aldehyde 38, then reduction and Appel reaction.22 Unfortu-
nately, we never succeeded to achieve an efficient lithiation/
formylation, probably due to the generation of the unstable
benzyne intermediate.
More recently, we considered a C−H activation approach to
36 based on recent work of Hartwig and co-workers.23 Indeed,
a sequence of iridium-catalyzed C−H borylation and copper-
catalyzed methylation would allow to bridge our first and
second synthetic routes. The C−H borylation of ester 15
should be selective for the less hindered position, as
demonstrated by Hartwig and co-workers for di- and
trisubstituted arenes,24 and the Cu-catalyzed methylation of
the corresponding boronate would lead to the desired aryl
bromide 36. We applied this method to aryl bromide 15 and
were pleased to obtain the corresponding borylated
intermediate in 97% yield in a highly regio- and chemoselective
manner (Scheme 6, bottom). The subsequent methylation
worked well too, providing a yield of 80%. The global sequence
from 3-bromo-2-methylphenol 25 (see Scheme 4) is as
effective as the previous one from 2,5-xylenol 34, with an
overall yield of 58% for the same number of steps. However,
the C−H borylation approach is arguably more elegant, since it
avoids both harsh reaction conditions in the perbromination
and debromination steps and a difficult separation of the
undesired benzyl bromide isomer after radical bromination.
Moreover, the borylated intermediate could be potentially
useful to prepare analogues via different reactions.25
Next, 36 was engaged in the previously optimized C(sp3)−
H arylation in the presence of IBiox ligand L2, to give the
indane 39 in 87% yield (Scheme 7). Then, similarly to the first
route, both methoxy groups were cleaved under acidic
condition (87% yield), the corresponding phenol-carboxylic
acid was alkylated and allylated (89% yield) and the aromatic
Claisen rearrangement furnished indane 40 (88% yield). The
latter, obtained in 34.5% overall yield over 9 steps from phenol
25, was used as a common intermediate to prepare the three
target racemic natural products. Compound 40 was first
engaged in the Lemieux−Johnson oxidation, followed by
reduction with sodium borohydride to yield the corresponding
alcohol in 75% yield over two steps. The saponification of this
product proceeded well and the corresponding carboxylic acid
was directly engaged in the oxidation step without purification.
The benzoquinone formation failed under previous conditions
with salcomine and oxygen. Gratifyingly, we found that this
oxidation proceeded cleanly using conditions developed by
Yakura and Konishi,26 whereby a catalytic hypervalent iodine
reagent is generated from iodophenoxyacetic acid 41 and
Oxone. Under these mild conditions, (±)-puraquinonic acid
was obtained in 82% yield over two steps and an overall yield
Scheme 6. Preparation of Methylated Aryl Bromide 36a
aReagents and conditions: (a) Br2, AlBr3, CH2Cl2, 0 °C; (b) HI aq.,
reflux; (c) K2CO3, MeI, acetone, reflux; (d) N-bromosuccinimide,
AIBN, CCl4, reflux; (e)
iPrCO2Me, LDA, THF, 0 °C, then benzyl
bromide, 0→ 25 °C; (f) [Ir(COD)OMe]2 (1.25 mol %), dtbbpy (2.5
mol %), B2Pin2, THF, 50 °C; (g) CuI (10 mol %), LiI (20 mol %),
tBuOLi, PO(OMe)3, DMI, 50 °C. dtbbpy = 4,4′-di-tert-butyl-2,2′-
dipyridyl; DMI = 1,3-dimethyl-2-imidazolidinone.
of 22.3% over 13 steps. (±)-Deliquinone was obtained in a
similar fashion. The double bond of 40 was oxidized under
Lemieux−Johnson conditions and both aldehyde and ester
groups were reduced using lithium aluminum hydride. Phenol
oxidation under the same conditions as puraquinonic acid
provided racemic deliquinone in 76% yield over three steps
and an overall yield of 26.2% over 12 steps. To prepare
russujaponol F, phenol 40 was triflated under classic
conditions (87% yield). The corresponding triflate was
engaged in a Pd0-catalyzed cross-coupling under conditions
developed by Woodward and co-workers, using the air-stable
DABAL-Me3 [DABCO-bis(trimethylaluminum)] complex.
27
These efficient and convenient conditions furnished 42 in
excellent yield (98%). Finally, racemic russujaponol F was
obtained by Lemieux−Johnson oxidation and reduction of
both carbonyl groups in 87% yield over two steps and an
overall yield of 25.6% over 13 steps. The current syntheses of
(±)-puraquinonic acid and deliquinone are more efficient than
the best previously reported syntheses by Clive and co-workers
and Kraus and co-workers, respectively. Moreover, (±)-russu-
japonol F was synthesized for the first time.
Enantioselective Synthesis. After having completed the
racemic syntheses, we directed our efforts toward the
development of enantioselective versions. Investigations of
the asymmetric C(sp3)−H activation of the model aryl
bromide 15 (see Table 1), which were detailed earlier,14 led
us to opt for a chiral substrate/chiral ligand combination. We
prepared the L-proline amide 43 in 84% yield via saponification
and amide formation under Schotten−Baumann conditions
(Scheme 8). This substrate was engaged in the asymmetric
C(sp3)−H activation using ligand L3, a chiral bulky NHC
developed by Kündig and co-workers,28 which furnished
indane 44 in 87% yield and 85:15 diastereomeric ratio.
Then, the proline and methoxy groups were cleaved with
hydrobromic acid to provide the corresponding phenol-
carboxylic acid 45 in 92% yield. After significant experimenta-
tion, we found that this intermediate slowly recrystallized in a
mixture of chloroform and cyclohexane. The crystalline
material was racemic, and the recovered mother liquor showed
an enantiomeric ratio of 96:4. Despite this loss of material in
the crystallization, this global sequence of deprotection and
recrystallization occurred in 57% yield. At this point, we tried
to determine the absolute configuration of the generated
quaternary stereocenter using X-ray diffraction analysis, but
unfortunately, despite numerous attempts, neither the
enantioenriched compound 45, nor any derivative that we
synthesized29 furnished suitable crystals. The configuration was
finally ascribed as (S) by NOESY NMR of a Mosher derivative
and vibrational circular dichroism,14 and this assignment was
later confirmed by the specific rotation values of the target
products. With the enantioenriched intermediate 45 in hand,
we employed the same sequence as for the racemic synthesis,
and obtained comparable yields. In this manner, (S)-
puraquinonic acid ([α]D
20 + 1.4, lit. for the (R) enantiomer:
− 2.2)6c,d was obtained in 15 steps, 9.8% overall yield, (S)-
deliquinone ([α]D
20 + 0.9, lit. for the (R) enantiomer: − 0.5)3 in
14 steps and 9.9% overall yield, and (S)-russujaponol F ([α]D
20
+ 2.1, lit. + 1.3)4 in 15 steps and 12.3% overall yield. These
specific rotations confirmed the configuration assignment of
intermediate 45. Therefore, we prepared natural russujaponol
F, ent-puraquinonic acid, and ent-deliquinone.
■ CONCLUSION
In conclusion, three (nor)illudalane sesquiterpenes were
synthesized in racemic and enantioenriched forms from a
common indane intermediate. The latter was obtained by Ir-
catalyzed C−H borylation and Pd0-catalyzed C(sp3)−H
arylation as key steps, and an asymmetric version of the C−
H arylation allowed the construction of the isolated, highly
symmetric quaternary stereocenter. This work, representing
the first application of Pd0-catalyzed enantioselective C(sp3)−
H activation to natural product synthesis, highlights the
challenges and potential of this transformation for the synthesis
of chiral bioactive molecules.
■ EXPERIMENTAL SECTION
General Methods. All reactions involving air-sensitive material
were carried out in predried glassware under an argon atmosphere by
using Schlenk techniques employing double-line argon-vacuum lines
and working in an argon-filled glovebox. An oil bath was used as
heating source unless otherwise noted. Analytical thin layer
chromatography (TLC) was performed using precoated Merck silica
gel 60 F254 plates (0.25 mm). Visualization of the developed
chromatogram was performed by UV absorbance (254 nm) or TLC
stains (KMnO4 and Phosphomolybdic acid). Flash chromatography
was performed using Silicycle SiliaFlash P60 (230−400 mesh) with
the indicated solvent system, using gradients of increasing polarity in
most cases. Anhydrous solvents were purchased from Acros Organics
or Sigma-Aldrich. The solvents were degassed by three cycles of
freeze−pump−thaw and storing in single-necked flasks equipped with
a JYoung PTFE valve when necessary. Palladium complexes were
purchased from Sigma-Aldrich or Strem. All other chemical reagents
Scheme 7. Divergent Synthesis of (±)-Puraquinonic Acid,
(±)-Deliquinone, and (±)-Russujaponola
aReagents and conditions: (a) [Pd(π-cinnamyl)Cl]2 (5 mol %), L
2
(10 mol %), CsOPiv, Cs2CO3, mesitylene, 160 °C; (b) HBr aq.,
AcOH, reflux; (c) KHCO3, MeI, DMF, 40 °C, then NaH, allyl
bromide; (d) PhNEt2, 200 °C; (e) OsO4 (5 mol %), NaIO4, AcOEt/
H2O, 25 °C; (f) NaBH4, MeOH, 0 °C; (g) LiOH aq., dioxane, reflux;
(h) 41 (10 mol %), Oxone, CF3CH2OH/H2O, 25 °C; (i) LiAlH4,
THF, 0 → 25 °C; (j) Tf2O, pyridine, CH2Cl2, 0 → 25 °C; (k)
[Pd2dba3·CHCl3] (2.5 mol %), XPhos (5 mol %), DABCO·2AlMe3,
THF, reflux. DABCO = 1,4-diazabicyclo[2.2.2]octane; XPhos = 2-
dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl.
were purchased from Sigma-Aldrich, Acros Organics, Alfa Aesar,
Apollo scientific and Fluorochem and used as received without further
purification unless otherwise stated. GC−MS analyses were
performed with a Shimadzu QP2010SB GC−MS apparatus on a
Rtx-5 ms-LowBleed column lined with a mass (EI) detection system.
HPLC analyses was performed using a Shimadzu Prominence system
with SIL-20A auto sample, CTO-20AC column oven, LC-20AD
pump system, DGU20A3 degasser and SPD-M20A Diode Array or
UV/vis detector. The following chiral columns from Daicel Chemical
Industries were used: OJ-H (Chiralcel), IA (Chiralpak) in 4.6 × 250
mm size. Melting points were obtained on a Büchi melting point M-
565, and are uncorrected.
IR spectra were recorded on an ATR Varian Scimitar 800 and are
reported in reciprocal centimeters (cm−1). Nuclear magnetic
resonance spectra were recorded on a Bruker Advance 400 (400
MHz), Advance 500 (500 MHz) and Advance 600 (600 MHz) in
deuterated chloroform (residual peaks 1H δ 7.26 ppm, 13C δ 77.16
ppm) unless otherwise noted. 19F NMR spectra were referenced to
external CFCl3. Data are reported in parts per million (ppm) as
follows: chemical shift, multiplicity (s = singlet, d = doublet, t =
triplet, q = quartet, quint = quintuplet, sept = septuplet, m = multiplet
and brs = broad singlet), coupling constant in Hz and integration.
High resolution mass spectra were recorded by Dr. H. Nadig, Dr. M.
Pfeffer and S. Mittelheisser (Department of Chemistry, University of
Basel) on a Bruker maXis 4G QTOF ESI mass spectrometer. Optical
rotations were measured on a PerkinElmer 341 Polarimeter in a 1 mL
micro cuvette (cell length 100 mm) with NaD-Line (λ = 589 nm).
The concentration (c) was given in g/100 mL.
3-Bromo-2-methylphenol (25)..14,17 Freshly distilled 3-bromo-
2-methylaniline (70 g, 376 mmol) was added to an aqueous 1 M
solution of sulfuric acid (451 mL, 451 mmol) at 0 °C under vigorous
stirring (formation of a white suspension of anilinium). Then a
saturated solution of sodium nitrite (31.1 g, 451 mmol) in water was
added dropwise at −5 °C. After stirring at −5 °C for 20 min (most of
the solid is dissolved at this point), concentrated sulfuric acid (14 mL,
258 mmol) was added and the solution was heated at 100 °C for 1 h.
The mixture was then diluted with water, extracted with Et2O, dried
and concentrated to yield a black slurry. The residue was purified by
sublimation under a vacuum (0.1 mbar), and the obtained orange
solid was recrystallized with cyclohexane to yield 25 as a white
crystalline solid (32 g, 171 mmol, 46% yield): Rf 0.25 (85:15 PE/
AcOEt); mp 96−98 °C; 1H NMR (500 MHz, CDCl3) δ 7.14 (dd, J =
8.0, 1.1 Hz, 1H), 6.92 (td, J = 8.0, 0.5 Hz, 1H), 6.71 (ddd, J = 8.0, 1.1,
0.5 Hz, 1H), 4.87 (s, 1H), 2.34 (s, 3H); 13C{1H} NMR (126 MHz,
CDCl3) δ 154.5, 127.6, 126.2, 125.1, 124.6, 114.2, 15.7; IR νmax/cm
−1
(neat) 3283, 1435, 1241, 998, 762 cm−1; GC−MS (EI) m/z [M]+·
calcd for C7H7
79BrO 186, found 186.
Methyl 3-(2-bromo-6-methoxyphenyl)-2,2-dimethylpropa-
noate (15).14 3-Bromo-2-methylphenol (25) (17.8 g, 95 mmol)
was dissolved in DMF (240 mL) and K2CO3 (39.4 g, 285 mmol, 3
equiv) was added; the mixture was then stirred during 5 min at room
temperature. After this period, methyl iodide (29.6 mL, 475 mmol, 5
equiv) was added in one portion and the reaction was stirred at 50 °C
during 2 h. The reaction was then diluted with water, extracted with
EtOAc and concentrated to yield the corresponding anisole which was
used in the next step without further purification. This anisole was
mixed with N-bromosuccinimide (17.75 g, 100 mmol, 1.05 equiv) and
benzoyl peroxide (75%) (1.23 g, 3.8 mmol, 4 mol %) in CCl4 (190
mL) and was heated to reflux and stirred overnight. The reaction
mixture was then cooled to room temperature and filtered. The filtrate
was diluted with DCM and washed successively with 2 M NaOH,
water and brine. The organic layer was dried over MgSO4, filtered and
concentrated under reduced pressure to give the corresponding
benzyl bromide which was used in the next step without further
purification. A solution of LDA (100 mmol, 1.05 equiv) in THF (190
mL) was prepared from diisopropylamine (14 mL, 100 mmol, 1.05
equiv) and 2.5 M nBuLi in hexane (40 mL, 100 mmol, 1.05 equiv),
stirred at 0 °C during 15 min. To the LDA solution, methyl
isobutyrate (10.9 mL, 95 mmol, 1 equiv) was added dropwise at 0 °C
and the mixture was stirred at the same temperature for 45 min. The
benzyl bromide, obtained previously, in THF (95 mL) was added
slowly to the solution always at 0 °C. The mixture was stirred for 16 h
with the ice bath warming to room temperature. Water was then
added to the reaction at 0 °C. The mixture was extracted three times
with Et2O; the combined organic layers were washed with brine. The
organic layer was dried over MgSO4, filtered, concentrated under a
Scheme 8. Divergent Synthesis of (S)-Puraquinonic Acid, (S)-Deliquinone, and (S)-Russujaponola
aReagents and conditions: (a) LiOH aq., THF/MeOH, 80 °C; (b) (COCl)2, DMF cat., CH2Cl2, 25 °C, then L-Pro-O
iPr; (c) [Pd(π-cinnamyl)Cl]2
(5 mol %), L3 (10 mol %), CsOPiv, Cs2CO3, mesitylene, 160 °C; (d) HBr aq., AcOH, reflux, then recrystallization from CHCl3/C6H12 3:1; (e)
KHCO3, MeI, DMF, 40 °C, then NaH, allyl bromide; (f) PhNEt2, 200 °C; (g) OsO4 (5 mol %), NaIO4, AcOEt/H2O, 25 °C; (h) NaBH4, MeOH,
0 °C; (i) LiOH aq., dioxane, reflux; (j) 41 (10 mol %), Oxone, CF3CH2OH/H2O, 25 °C; (k) LiAlH4, THF, 0 → 25 °C; (l) Tf2O, pyridine,
CH2Cl2, 0 → 25 °C; (m) [Pd2dba3·CHCl3] (2.5 mol %), XPhos (5 mol %), DABCO·2AlMe3, THF, reflux.
bMeasured by HPLC on a chiral
stationary phase using the racemic compound as reference.
vacuum and purified by column chromatography (Cy/AcOEt: 95/5
to 90/10) to yield 15 as a colorless oil (21.4 g, 71 mmol, 75% over 3
steps) that solidified upon standing: Rf 0.22 (90:10 PE/AcOEt); mp
42−44 °C; 1H NMR (500 MHz, CDCl3) δ 7.16 (dd, J = 8.1, 1.1 Hz,
1H), 7.04 (t, J = 8.1 Hz, 1H), 6.76 (dd, J = 8.1, 1.1 Hz, 1H), 3.74 (s,
3H), 3.67 (s, 3H), 3.18 (s, 2H), 1.21 (s, 6H); 13C{1H} NMR (126
MHz, CDCl3) δ 178.3, 159.1, 128.4, 127.4, 127.3, 125.2, 109.3, 55.6,
51.8, 43.4, 39.3, 25.6; IR νmax/cm
−1 (neat) 2980, 1716, 1265, 1146,
1029, 771 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for
C13H17
79BrNaO3 323.0253, found 323.0251.
Methyl 3-(2-bromo-3-methoxyphenyl)-2,2-dimethylpropa-
noate (16). 2-Bromo-1-methoxy-3-methylbenzene (26) (1.16 g,
5.77 mmol) was mixed with N-bromosuccinimide (1.08 g, 6.06 mmol,
1.05 equiv) and benzoyl peroxide (75%) (75 mg, 0.23 mmol, 4 mol
%) in CCl4 (13 mL) and was heated to reflux and stirred overnight.
The reaction mixture was then cooled to room temperature and
filtered. The filtrate was diluted with DCM and washed successively
with 2 M NaOH, water and brine. The organic layer was dried over
MgSO4, filtered and concentrated under reduced pressure to give the
corresponding benzyl bromide which was used in the next step
without further purification. A solution of LDA (6.06 mmol, 1.05
equiv) in THF (12 mL) was prepared from diisopropylamine (0.85
mL, 6.06 mmol, 1.05 equiv) and 2.5 M nBuLi in hexane (2.43 mL,
6.06 mmol, 1.05 equiv), stirred at 0 °C during 15 min. To the LDA
solution, methyl isobutyrate (0.66 mL, 5.77 mmol, 1 equiv) was
added dropwise at 0 °C and the mixture was stirred at the same
temperature for 45 min. The benzyl bromide, obtained previously, in
THF (6 mL) was added slowly to the solution always at 0 °C. The
mixture was stirred for 16 h with the ice bath warming to room
temperature. Water was then added to the reaction at 0 °C. The
mixture was extracted three times with Et2O; the combined organic
layers were washed with brine. The organic layer was dried over
MgSO4, filtered, concentrated under a vacuum and purified by
column chromatography (Cy/AcOEt: 95/5 to 90/10) to yield 16
(1.35 g, 4.48 mmol, 78%) as a colorless oil: Rf 0.24 (90:10 PE/
AcOEt); 1H NMR (500 MHz, CDCl3) δ 7.16 (t, J = 7.9 Hz, 1H),
6.79−6.72 (m, 2H), 3.88 (s, 3H), 3.69 (s, 3H), 3.18 (s, 3H), 1.23 (s,
6H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.1, 156.2, 139.8, 127.4,
123.5, 115.9, 110.0, 77.4, 77.2, 76.9, 56.5, 52.0, 44.5, 44.4, 25.2; IR
νmax/cm
−1 (neat) 2974, 2948, 1728, 1468, 1431, 1029, 1264, 1127,
1068, 780 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for
C13H17
79BrNaO3 323.0253, found 323.0257.
Methyl 3-(2-bromophenyl)-2,2-dimethylpropanoate (28).14
A solution of LDA (8.4 mmol, 1.05 equiv) in THF (17 mL) was
prepared from diisopropylamine (1.18 mL, 8.4 mmol, 1.05 equiv) and
2.5 M nBuLi in hexane (3.36 mL,8.4 mmol, 1.05 equiv), stirred at 0
°C during 15 min. To the LDA solution, methyl isobutyrate (0.92 mL,
8 mmol, 1 equiv) was added dropwise at 0 °C and the mixture was
stirred at the same temperature for 45 min. Then 2-bromobenzyl
bromide (2 g, 8 mmol, 1 equiv) in THF (8 mL) was added slowly to
the solution always at 0 °C. The mixture was stirred for 16 h with the
ice bath warming to room temperature. Water was then added to the
reaction at 0 °C. The mixture was extracted three times with Et2O;
the combined organic layers were washed with brine. The organic
layer was dried over MgSO4, filtered, concentrated under a vacuum
and purified by column chromatography (Cy/AcOEt: 95/5 to 90/10)
to yield 28 (1.97 g, 7.26 mmol, 91%) as a colorless oil: Rf 0.35 (90:10
PE/AcOEt); 1H NMR (500 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 1.3 Hz,
1H), 7.20 (td, J = 7.5, 1.3 Hz, 1H), 7.13 (dd, J = 7.8, 1.8 Hz, 1H),
7.06 (ddd, J = 7.9, 7.2, 1.8 Hz, 1H), 3.69 (s, 3H), 3.12 (s, 2H), 1.24
(s, 6H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.0, 137.9, 133.2,
131.5, 128.2, 127.2, 126.2, 52.0, 44.4, 44.4, 25.1; IR νmax/cm
−1 (neat)
2977, 2950, 1728, 1469, 1192, 1134, 1024, 749 cm−1; HRMS (ESI)
m/z [M + Na]+ calcd for C13H17
79BrNaO3 323.0253, found 323.0257.
Methyl 4-methoxy-2-methyl-2,3-dihydro-1H-indene-2-car-
boxylate (14).14 In an oven dry Schlenk tube, 15 (1.36 g, 4.5
mmol) was introduced. Then the Schlenk tube was transferred in a
glovebox, and [Pd(π-cin)Cl]2 (117 mg, 0.23 mmol, 5 mol %), L
2 (161
mg, 0.45 mmol, 10 mol %), cesium pivalate (1.05 g, 4.5 mmol, 1
equiv) and cesium carbonate (2.20 g, 6.75 mmol, 1.5 equiv) were
introduced and the tube was close with a septum. Outside of the
glovebox, mesitylene (45 mL) was added. The reaction was stirred at
room temperature for 10 min. The tube was then introduced in a 160
°C preheated oil bath and stirred at this temperature for 18 h. After
this period the reaction was cooled to room temperature and filtered
over a pad of Celite (washed with DCM). The crude material was
analyzed by GC−MS and then concentrated and purified by flash
column chromatography (Cy/AcOEt: 95/5 to 90/10) to yield the
corresponding indane 14 (915 mg, 4.15 mmol, 92%) as a yellowish
oil: Rf 0.21 (95:5 PE/AcOEt);
1H NMR (500 MHz, CDCl3) δ 7.15
(t, J = 7.8 Hz, 1H), 6.81 (d, J = 7.8 Hz, 1H), 6.68 (d, J = 7.8 Hz, 1H),
3.82 (s, 3H), 3.72 (s, 3H), 3.50 (d, J = 16.0 Hz, 1H), 3.39 (d, J = 16.4
Hz, 1H), 2.84 (d, J = 16.4 Hz, 1H), 2.82 (d, J = 16.0 Hz, 1H), 1.37 (s,
3H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.3, 156.3, 143.3, 128.9,
128.2, 117.1, 108.2, 55.3, 52.2, 49.4, 44.5, 41.0, 25.6; IR νmax/cm
−1
(neat) 2950, 1730, 1590, 1261, 1075, 766 cm−1; HRMS (ESI) m/z
[M + Na]+ calcd for C13H16NaO3 243.0992, found 243.0990.
Methyl 4-(allyloxy)-2-methyl-2,3-dihydro-1H-indene-2-car-
boxylate (30). 14 (911 mg, 4.14 mmol) was dissolved in glacial
acetic acid (11 mL) and 48% aqueous hydrobromic acid (54 mL).
The reaction mixture was refluxed for 2 h. After this period, the
reaction was diluted with water and extracted with DCM. The organic
layer was dried over MgSO4 and concentrated under a vacuum. Two
portions of toluene were added and evaporated to remove excess of
AcOH. The crude product was then diluted in DMF (6 mL) and
KHCO3 (1.12 g, 12.42 mmol, 3 equiv) was added. The suspension
was stirred 10 min at room temperature, and then methyl iodide (0.77
mL, 12.42 mmol, 3 equiv) was added. The mixture was stirred at 40
°C until total consumption of starting material (approximately 3 h).
To remove the excess of iodomethane, the reaction was heated to 65
°C under a flow of argon for 15 min. After this period, the
temperature was lowered to 40 °C, and then NaH (300 mg, 12.42
mmol, 3 equiv) and allyl bromide (1.07 mL, 12.42 mmol, 3 equiv)
were added successively carefully. The reaction mixture was stirred for
30 min and then cooled with an ice bath, and then water was added.
The reaction was extracted three times with DCM. The combined
organic phases were dried over MgSO4, filtered and concentrated
under reduced pressure. The crude material was purified by flash
column chromatography (Cy/AcOEt: 90/10) leading to 30 as a light
yellow oil (835 mg, 3.39 mmol, 82% over 2 steps): Rf 0.33 (90:10 PE/
AcOEt); 1H NMR (400 MHz, CDCl3) δ 7.12 (t, J = 7.8 Hz, 1H),
6.81 (d, J = 7.5 Hz, 1H), 6.67 (d, J = 8.1 Hz, 1H), 6.06 (ddt, J = 17.3,
10.4, 5.1 Hz, 1H), 5.42 (dq, J = 17.3, 1.6 Hz, 1H), 5.27 (dq, J = 10.4,
1.6 Hz, 1H), 4.54 (dt, J = 5.1, 1.6 Hz, 2H), 3.72 (s, 3H), 3.51 (d, J =
16.0 Hz, 1H), 3.42 (d, J = 16.4 Hz, 1H), 2.89 (d, J = 16.4 Hz, 1H),
2.82 (d, J = 16.0 Hz, 1H), 1.38 (s, 3H); 13C{1H} NMR (63 MHz,
CDCl3) δ 178.3, 155.3, 143.4, 133.6, 129.3, 128.1, 117.3, 117.2, 109.5,
68.7, 52.2, 49.4, 44.5, 41.1, 25.6; IR νmax/cm
−1 (neat) 2950, 1730,
1590, 1480, 1262, 1112, 1061, 767 cm−1; HRMS (ESI) m/z [M +
Na]+ calcd for C15H18NaO3 269.1148, found 269.1151.
Methyl 5-allyl-4-hydroxy-2-methyl-2,3-dihydro-1H-indene-
2-carboxylate (31). A sealed tube charged with 30 (409 mg, 1.66
mmol) and N,N-diethylaniline (3 mL) was heated under stirring at
200 °C for 24 h. After this period, the reaction was poured into 1 M
HCl and extracted three times with DCM. The combined organic
layers were dried over MgSO4, filtered and concentrated under
reduced pressure. The crude material was purified by flash
chromatography (Cy/AcOEt: 90/10) leading to 31 (368 mg, 1.49
mmol, 90%) as a yellow oil: Rf 0.20 (85:15 PE/AcOEt);
1H NMR
(400 MHz, CDCl3) δ 6.93 (d, J = 7.5 Hz, 1H), 6.73 (d, J = 7.5 Hz,
1H), 6.01 (ddt, J = 16.5, 10.0, 6.4 Hz, 1H), 5.21−5.10 (m, 2H), 4.99
(brs, 1H), 3.72 (s, 3H), 3.47 (d, J = 16.0 Hz, 1H), 3.42−3.35 (m,
3H), 2.80 (d, J = 16.0 Hz, 1H), 2.80 (d, J = 15.9 Hz, 1H), 1.38 (s,
3H); 13C{1H} NMR (63 MHz, CDCl3) δ 178.4, 150.8, 141.8, 137.0,
129.2, 127.3, 123.3, 116.9, 116.3, 52.3, 49.9, 44.2, 40.3, 35.0, 25.5; IR
νmax/cm
−1 (neat) 3460, 2952, 1712, 1445, 1284, 1209, 1114, 913
cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C15H18NaO3 269.1148,
found 269.1147.
Methyl 4-hydroxy-5-(2-hydroxyethyl)-2-methyl-2,3-dihy-
dro-1H-indene-2-carboxylate (31a). In a round-bottom flask
containing a stirred biphasic solution of 31 (441 mg, 1.79 mmol) in
EtOAc (20 mL) and water (12 mL) was added OsO4 (23 mg, 90.5
μmol, 5 mol %). After 5 min, NaIO4 (957 mg, 4.48 mmol, 2.5 equiv)
was added in two portions separated by 5 min. The solution was
vigorously stirred for 3 h at room temperature. The layers were
separated and the aqueous phase was extracted twice with ethyl
acetate. The combined organic layers were dried over MgSO4, filtered
and concentrated under reduced pressure. The crude material was
diluted in MeOH (20 mL) and cooled to 0 °C. After this, NaBH4
(205 mg, 5.42 mmol, 3 equiv) was added and the reaction was
allowed to reach room temperature. After 30 min, H2O was added
and the reaction was extracted three times with ethyl acetate. The
combined organic phases were dried over MgSO4, filtered and
concentrated under reduced pressure. The crude material was purified
by flash chromatography (Cy/AcOEt: 60/40) leading to 31a (389
mg, 1.55 mmol, 87%) as a light yellow oil. Rf 0.19 (70:30 PE/AcOEt);
1H NMR (400 MHz, CDCl3) δ 6.88 (d, J = 7.5 Hz, 1H), 6.69 (d, J =
7.5 Hz, 1H), 4.01−3.93 (m, 2H), 3.71 (s, 3H), 3.46 (d, J = 16.0 Hz,
1H), 3.40 (d, J = 16.2 Hz, 1H), 2.89−2.83 (m, 3H), 2.79 (d, J = 16.0
Hz, 1H), 1.37 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.5,
152.0, 142.3, 129.9, 128.7, 124.6, 116.6, 65.1, 52.3, 49.7, 44.3, 40.9,
34.5, 25.6; IR νmax/cm
−1 (neat) 3416, 3296, 2933, 1710, 1437, 1283,
1214, 1114, 1039, 809 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for
C14H18NaO4 273.1097, found 273.1098.
Methyl 5-(2-hydroxyethyl)-2-methyl-4,7-dioxo-2,3,4,7-tet-
rahydro-1H-indene-2-carboxylate (32). In a round-bottom flask,
31a (385 mg, 1.54 mmol) and Salcomine (202 mg, 0.62 mmol, 40
mol %) were mixed in acetonitrile (20 mL). Oxygen was bubbled
through the stirred suspension during 5 min. Then the reaction was
stirred under oxygen atmosphere during 24 h. After this period,
acetonitrile was removed under reduced pressure and the crude was
purified by flash chromatography (Cy/AcOEt: 50/50) leading to 32
(280 mg, 1.06 mmol, 69%) as a yellow oil: Rf 0.23 (50:50 PE/
AcOEt); 1H NMR (600 MHz, CDCl3) δ 6.58 (t, J = 1.2 Hz, 1H),
3.82 (t, J = 5.5 Hz, 2H), 3.72 (s, 3H), 3.38−3.31 (m, 2H), 2.74−2.69
(m, 2H), 2.68 (tt, J = 6.0, 1.0 Hz, 2H), 1.74 (brs, 1H), 1.39 (s, 3H);
13C{1H} NMR (151 MHz, CDCl3) δ 186.3, 185.9, 177.0, 146.6,
146.2, 146.0, 134.5, 61.2, 52.6, 47.3, 42.5, 42.2, 32.6, 26.1; IR νmax/
cm−1 (neat) 3492, 3447, 2955, 1729, 1650, 1268, 1211, 1039, 851
cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C14H16NaO5 287.0890,
found 287.0886.
Methyl 5-(2-hydroxyethyl)-2,6-dimethyl-4,7-dioxo-2,3,4,7-
tetrahydro-1H-indene-2-carboxylate (33). A solution of 33
(90.6 mg, 0.343 mmol), acetic acid (63.0 mg, 60 μL, 3 equiv) in
acetonitrile/H2O 1:1 (1 mL) was heated at 70 °C. Subsequently,
silver nitrate (17.5 mg, 0.103 mmol, 0.3 equiv) and ammonium
persulfate (102 mg, 0.446 mmol, 1.3 equiv) were added and the
reaction was stirred for 2 h. After this period, the solution was diluted
with ethyl acetate (15 mL). The organic layer was washed with water
(10 mL), dried over MgSO4 and concentrated under a vacuum. The
crude was purified by flash chromatography (Cy/AcOEt: 50/50)
leading to 33 (52 mg, 0.187 mmol, 55%) as a yellow oil: Rf 0.25
(50:50 PE/AcOEt); 1H NMR (600 MHz, CDCl3) δ 3.77−3.73 (m,
1H), 3.72 (s, 3H), 3.38−3.31 (m, 2H), 2.78 (t, J = 6.5 Hz, 2H),
2.75−2.69 (m, 2H), 2.07 (s, 3H), 1.65 (brs, 1H), 1.38 (s, 3H);
13C{1H} NMR (151 MHz, CDCl3) δ 186.4, 185.9, 177.1, 146.0,
145.6, 142.9, 141.5, 61.7, 52.6, 47.2, 42.6, 42.6, 30.1, 26.1, 12.3; IR
νmax/cm
−1 (neat) 3443, 2953, 1730, 1646, 1207, 1042, 714 cm−1;
HRMS (ESI) m/z [M + Na]+ calcd for C15H18NaO5 301.1046, found
301.1042.
2,4,5-Tribromo-3,6-dimethylphenol (34a)..14,20 Aluminum
(4.01 g, 0.15 mol, 0.45 equiv) was cautiously added in small portions
to bromine (100 mL, 1.94 mol, 5.8 equiv) cooled to 0 °C, and the
mixture was stirred for 20 min. A solution of 2,5-dimethylphenol (35)
(40.3 g, 330 mmol) in DCM (200 mL) was added over 2 h, and the
mixture was stirred for additional 2 h at 0 °C. (Caution! A copious
amount of HBr is evolved in this reaction which can be trapped by a water
trap connected to an aqueous sodium carbonate scrubber.) The reaction
was then diluted at 0 °C with DCM (200 mL) and water (200 mL).
Then a 5% aqueous NaHSO3 solution was added until the color of
bromine disappeared. The phases were separated, the aqueous layer
was extracted twice with DCM, and the combined organic layers were
dried with MgSO4, filtered and concentrated under reduced pressure
to yield 34a (115 g, 320 mmol) as a white solid which was used in the
next step without further purification: Rf 0.39 (90:10 PE/AcOEt); mp
179−182 °C; 1H NMR (400 MHz, CDCl3) δ 5.83 (s, 1H), 2.66 (s,
3H), 2.47 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 149.9, 136.2,
128.2, 125.3, 118.4, 112.7, 26.5, 19.1; IR νmax/cm
−1 (neat) 3491,
1365, 1444, 1032, 654 cm−1; HRMS (ESI) m/z [M − H]− calcd for
C8H6
79Br3O 354.7974, found 354.7976.
3-Bromo-2,5-dimethylphenol (34b)..14,20 A suspension of the
34a (115 g, 320 mmol) in aqueous HI (57%, 250 mL) was heated at
reflux under argon for 16 h and cooled. TBME (500 mL) was added,
and at 0 °C under stirring, NaHSO3 (40%, 900 mL) was added
dropwise. The layers were separated and the aqueous layer was
extracted twice with TBME (300 mL). The combined organic phases
were dried over MgSO4, filtered, and concentrated under reduced
pressure to yield 34b (54.7 g, 272 mmol) nearly pure as a light brown
solid which was used in the next step without further purification: Rf
0.29 (85:15 PE/AcOEt); mp 85−88 °C; 1H NMR (400 MHz,
CDCl3) δ 6.98 (s, 1H), 6.54 (s, 1H), 4.73 (s, 1H), 2.29 (s, 3H), 2.24
(s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ 154.1, 137.8, 125.8,
125.7, 121.3, 115.1, 20.78, 15.3; IR νmax/cm
−1 (neat) 3306, 2921,
1399, 1272, 1124, 1007, 814 cm−1; HRMS (ESI) m/z [M − H]−
calcd for C8H8
79BrO 198.9764, found 198.9765.
1-Bromo-3-methoxy-2,5-dimethylbenzene (35)..14,20 34b
(54.4 g, 271 mmol) was dissolved in acetone (500 mL), then
potassium carbonate (56.0 g, 405 mmol, 1.5 equiv) and methyl iodide
(51.0 mL, 115 g, 810 mmol, 3.0 equiv) were added. The resulting
dark brown mixture was stirred under reflux for 24 h; after 12 h,
another equivalent of methyl iodide (16.0 mL, 270 mmol, 1.0 equiv)
was added. The dark brown suspension was concentrated carefully
under reduced pressure. The residue was diluted with diethyl ether
(700 mL) and water (500 mL) and the layers were separated. The
aqueous phase was extracted twice with diethyl ether (200 mL). The
combined organic phases were washed twice with water (200 mL),
then with brine (100 mL), dried over MgSO4, filtered, and
concentrated under reduced pressure. The crude material was
obtained as a brown liquid which was distilled under reduced
pressure to give 35 as a colorless liquid (53.47 g, 249 mmol, 76% over
3 steps): Rf 0.53 (95:5 PE/AcOEt); bp 54−59 °C at 0.1 mbar; 1H
NMR (400 MHz, CDCl3) δ 7.00 (s, 1H), 6.59 (s, 1H), 3.81 (s, 3H),
2.30 (s, 3H), 2.27 (s, 3H); 13C{1H} NMR (101 MHz, CDCl3) δ
158.2, 137.4, 125.6, 125.0, 123.8, 110.4, 55.9, 21.3, 15.4; IR νmax/cm
−1
(neat) 2925, 1264, 1144, 1046, 828 cm−1; GC−MS (EI) m/z [M]+·
calcd for C9H11
79BrO 214, found 214.
Methyl 3-(2-bromo-6-methoxy-4-(4,4,5,5-tetramethyl-1,3,2-
dioxaborolan-2-yl)phenyl)-2,2-dimethylpropanoate (15a). In
an oven dry Schlenk tube, 15 (1.0 g, 3.32 mmol), 4,4′-di-tert-butyl-
2,2′-dipyridyl (22.3 mg, 83 μmol, 2.5 mol %) and Bis(pinacolato)-
diboron (843 mg, 3.32 mmol, 1 equiv) were charged. Then, this
Schlenk tube was transferred in a glovebox, and [Ir(COD)OMe]2
(27.5 mg, 41.5 μmol, 1.25 mol %) was added. The tube was closed
with a septum and transferred outside of the glovebox. The reaction
was diluted with THF (10 mL) and heated at 50 °C during 48 h.
Afterward, THF was removed under a vacuum, and the crude was
purified by column chromatography to yield 15a as a white solid (1.38
g, 3.23 mmol, 97% yield): Rf 0.3 (80:20 PE/AcOEt); mp 81−84 °C;
1H NMR (500 MHz, CDCl3) δ 7.61 (s, 1H), 7.14 (s, 1H), 3.78 (s,
3H), 3.66 (s, 3H), 3.20 (s, 2H), 1.34 (s, 12H), 1.20 (s, 6H); 13C{1H}
NMR (126 MHz, CDCl3) δ 178.2, 158.6, 131.5, 130.5, 127.2, 114.6,
84.3, 55.7, 51.9, 43.5, 39.5, 25.6, 25.0; IR νmax/cm
−1 (neat) 2977,
1720, 1350, 1141, 1046, 853, 694 cm−1; HRMS (ESI) m/z [M + Na]+
calcd for C19H28B
79BrNaO5 449.1109, found 449.1098.
Methyl 3-(2-bromo-6-methoxy-4-methylphenyl)-2,2-dime-
thylpropanoate (36).14 From 35: 35 (3.50 g, 16.3 mmol) was
dissolved in tetrachloromethane (20 mL) and N-bromosuccinimide
(3.77 g, 21.2 mmol, 1.32 equiv) was added followed by AIBN (321
mg, 1.86 mmol, 12 mol %). The resulting light yellow suspension was
stirred under refluxed overnight. The reaction mixture was cooled in
an ice bath, filtered and washed with a minimal amount of cold DCM.
The filtrate was concentrated under reduced pressure to give an
orange oil which was used without further purification. A solution of
LDA (25.3 mmol, 1.55 equiv) in THF (25 mL) was prepared from
freshly distilled diisopropylamine (25.3 mmol, 1.55 equiv) and 2.5 M
(titrated) n-BuLi in hexane (10.1 mL, 25.3 mmol, 1.55 equiv), mixed
for 15 min at 0 °C. To the LDA solution, methyl isobutyrate (24.5
mmol, 1.5 equiv) was added dropwise at 0 °C and the mixture was
stirred at 0 °C for 45 min. Freshly prepared crude 3-bromo-2-
bromomethyl-5-methyl-methoxybenzene from the previous step was
diluted in THF (16 mL) and added slowly to the LDA solution at 0
°C. The mixture was slowly warmed to room temperature and stirred
for 16 h. The reaction was quenched at 0 °C with water (30 mL). The
mixture was extracted three times with diethyl ether (30 mL); the
combined organic layers were washed with brine, dried over MgSO4,
filtered and then concentrated in vacuum to give the crude ester. The
crude material was purified by flash column chromatography to yield
36 as a colorless oil, which crystallized on standing (3.85 g, 12.2
mmol, 75% yield over 2 steps). From 15a: in an oven dry Schlenk
tube, 15a (1.28 g, 3 mmol) was introduced. Then, this Schlenk tube
was transferred in a glovebox, and CuI (57 mg, 0.3 mmol, 10 mol %),
LiI (80 mg, 0.6 mmol, 20 mol %) and tBuOLi (480 mg, 6 mmol, 2
equiv) were added. The tube was closed with a septum and
transferred outside of the glovebox. The reaction was diluted with
DMI (4.5 mL) and trimethyl phosphate (0.73 mL, 6 mmol, 2 equiv)
was added. The mixture was heated at 50 °C during 16 h. The
reaction was quenched by H2O, extracted by toluene. The organic
layer was condensed, and the residue was purified by flash column
chromatography to yield 36 as a colorless oil, which crystallized on
standing (3.85 g, 12.2 mmol, 75% yield over 2 steps): Rf 0.26 (90:10
PE/AcOEt); mp 63−65 °C; 1H NMR (400 MHz, CDCl3) δ 7.00 (s,
1H), 6.57 (s, 1H), 3.72 (s, 3H), 3.66 (s, 3H), 3.13 (s, 2H), 2.29 (s,
3H), 1.20 (s, 6H); 13C{1H} NMR (101 MHz, CDCl3) δ 178.4, 158.8,
138.6, 126.9, 125.6, 124.2, 110.4, 55.5, 51.8, 43.4, 39.0, 25.6, 21.3; IR
νmax/cm
−1 (neat) 2968, 1719, 1266, 1148, 1042, 822 cm−1; HRMS




carboxylate (39).14 In an oven dry catalysis tube, 36 (506 mg,
1.15 mmol) was introduced. Then the tube was transferred in a
glovebox, and [Pd(π-cin)Cl]2 (29.8 mg, 57.5 μmol, 5 mol %), L
2
(67.7 mg, 115 μmol, 10 mol %), cesium pivalate (269 mg, 1.15 mmol,
1 equiv) and cesium carbonate (562 mg, 1.72 mmol, 1.5 equiv) were
introduced, and the tube was closed with a septum. Outside of the
glovebox, mesitylene (6 mL) was added. The reaction was stirred at
room temperature for 10 min, and then, under pressure of argon, the
septum was rapidly exchanged for a screw cap. The tube was then
introduced in a 160 °C preheated aluminum heating block and stirred
at this temperature for 18 h. After this period the reaction was cooled
to room temperature, diluted with DCM (6 mL), filtered over a pad
of Celite (washed three times with 6 mL of DCM). The crude
material was analyzed by GC−MS, then concentrated and purified by
flash column chromatography to yield 39 as a yellowish liquid (361
mg, 1.00 mmol, 87%): Rf 0.38 (95:5 PE/AcOEt);
1H NMR (500
MHz, CDCl3) δ 6.64 (s, 1H), 6.50 (s, 1H), 3.80 (s, 7H), 3.71 (s, 6H),
3.45 (d, J = 16.0 Hz, 3H), 3.33 (d, J = 16.1 Hz, 3H), 2.79 (d, J = 16.1
Hz, 3H), 2.76 (d, J = 16.0 Hz, 3H), 2.33 (s, 8H), 1.36 (s, 6H);
13C{1H} NMR (126 MHz, CDCl3) δ 178.4, 156.0, 143.3, 138.3,
125.9, 117.7, 109.4, 77.4, 77.2, 76.9, 55.3, 52.2, 49.5, 44.4, 40.8, 25.6,
21.8; IR νmax/cm
−1 (neat) 2950, 2843, 1730, 1593, 1461, 1317, 1199,
1111, 1083, 829 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for
C14H18NaO3 257.1154, found 257.1148.
3-(2-Bromo-6-methoxy-4-methylphenyl)-2,2-dimethylpro-
panoic acid (36a).14 36 (3.5 g, 11.1 mmol) was dissolved in a
mixture of THF (20 mL), MeOH (20 mL) and 2 M aqueous LiOH
(20 mL). The reaction was then heated at 80 °C for 6 h. After cooling
to room temperature, the organic solvents were removed under
reduced pressure. The obtained aqueous solution was washed with
diethyl ether, acidified to pH < 0 and extracted three times with
DCM. The combined organic layers were then dried over MgSO4,
filtered and concentrated under reduced pressure to yield 36a as a
yellow solid, which was engaged in the next step without further
purifications: Rf 0.3 (70:30 PE/AcOEt); mp 100−103 °C; 1H NMR
(400 MHz, CDCl3) δ 7.01 (s, 1H), 6.57 (s, 1H), 3.69 (s, 3H), 3.19 (s,
2H), 2.29 (s, 3H), 1.22 (s, 6H); 13C{1H} NMR (63 MHz, CDCl3) δ
184.9, 158.8, 138.7, 126.9, 125.6, 123.8, 110.4, 54.9, 43.2, 39.1, 25.2,
21.3; IR νmax/cm
−1 (neat) 2974, 2939, 1691, 1271, 1159, 1045, 830




methylpropanoyl)-L-prolinate (43).14 36a from the previous
step was dissolved in dry DCM (90 mL), and then oxalyl chloride
(1.05 mL, 12.2 mmol, 1.1 equiv) was added, followed by a few drops
of DMF to initiate the reaction. After 1 h of stirring at room
temperature, the reaction was cooled to 0 °C and H-L-Pro-OiPr·HCl
(6.45 g, 33.3 mmol, 3 equiv) and 1 M aqueous NaOH (110 mL, 110
mmol, 10 equiv) were added in one portion. The mixture was
vigorously stirred for 16 h with the ice bath warming to room
temperature. The organic layer was then separated, washed with 2 M
HCl, dried over MgSO4, filtered and concentrated under reduced
pressure. Crude material was then purified by flash column
chromatography to yield 43 as a colorless wax, which crystallized
on standing (4.25 g, 9.66 mmol, 87%): Rf 0.24 (70:30 PE/AcOEt);
mp 75−79 °C; 1H NMR (500 MHz, CDCl3) δ 6.99 (s, 1H), 6.58 (s,
1H), 5.02 (sept, J = 6.3 Hz, 1H), 4.51−4.42 (m, 1H), 3.87−3.67 (m,
2H), 3.73 (s, 3H), 3.21 (d, J = 13.6 Hz, 1H), 3.13 (d, J = 13.6 Hz,
1H), 2.28 (s, 3H), 2.20−2.09 (m, 1H), 2.09−1.97 (m, 1H), 1.95−
1.76 (m, 2H), 1.29 (s, 3H), 1.25 (d, J = 6.3 Hz, 3H), 1.21 (d, J = 6.3
Hz, 3H), 1.17 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 176.4,
172.5, 158.9, 138.6, 126.9, 125.7, 124.2, 110.5, 68.1, 61.6, 55.5, 48.5,
44.1, 36.5, 28.0, 26.4, 26.0, 25.4, 21.9, 21.8, 21.2; IR νmax/cm
−1 (neat)
2977, 2932, 1741, 1615, 1400, 1161, 1040, 833 cm−1; HRMS (ESI)
m/z [M + Na]+ calcd for C21H30
79BrNNaO4 462.1250, found
462.1257; [α]D
23 −39.4° (c = 1.00, CHCl3).
Isopropyl ((S)-4-methoxy-2,6-dimethyl-2,3-dihydro-1H-in-
dene-2-carbonyl)-L-prolinate (44).14 In an oven dry catalysis
tube, 43 (506 mg, 1.15 mmol) was introduced. Then the tube was
transferred in a glovebox, and [Pd(π-cin)Cl]2 (29.8 mg, 57.5 μmol, 5
mol %), L3 (67.7 mg, 115 μmol, 10 mol %), cesium pivalate (269 mg,
1.15 mmol, 1 equiv) and cesium carbonate (562 mg, 1.72 mmol, 1.5
equiv) were introduced, and the tube was close with a septum.
Outside of the glovebox, mesitylene (6 mL) was added. The reaction
was stirred at room temperature for 10 min, and then, under pressure
of argon, the septum was rapidly exchange for a screw cap. The tube
was then introduced in a 160 °C preheated aluminum heating block
and stirred at this temperature for 18 h. After this period the reaction
was cooled to room temperature, diluted with DCM (6 mL), filtered
over a pad of Celite (washed three times with 6 mL of DCM). The
crude material was analyzed by GC−MS, then concentrated and
purified by flash column chromatography to yield 44 as a wax (361
mg, 1.00 mmol, 87%): Rf 0.29 (70:30 PE/AcOEt);
1H NMR (500
MHz, CDCl3) δ 6.64 (s, 1H), 6.50 (s, 1H), 5.02 (sept, J = 6.2 Hz,
1H), 4.48 (dd, J = 8.6, 4.8 Hz, 1H), 3.79 (s, 3H), 3.78−3.59 (m, 2H),
3.56 (d, J = 16.3 Hz, 1H), 3.33 (d, J = 16.2 Hz, 1H), 2.89 (d, J = 16.2
Hz, 1H), 2.80 (d, J = 16.3 Hz, 1H), 2.33 (s, 3H), 2.21−2.10 (m, 1H),
2.09−2.00 (m, 1H), 1.97−1.81 (m, 2H), 1.34 (s, 3H), 1.25 (d, J = 6.2
Hz, 3H), 1.19 (d, J = 6.2 Hz, 3H); 13C{1H} NMR (126 MHz,
CDCl3) δ 175.9, 172.2, 156.1, 143.1, 138.2, 125.6, 117.7, 109.2, 68.2,
60.9, 55.2, 49.7, 47.7, 44.7, 40.4, 28.3, 25.9, 25.4, 21.9, 21.8, 21.8; IR
νmax/cm
−1 (neat) 2976, 1736, 1626, 1400, 1185, 1108, 1085, 830
cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C21H29NNaO4
382.1989, found 382.1994; HPLC separation: with L2 Chiralpak IA;
95:5 (n-heptane/i-PrOH), 1.0 mL min−1, 205 nm, tR (major) = 12.8
min, tR (minor) = 22.2 min, 66:34 d.r., with L
3 Chiralpak IA; 95:5 (n-
heptane/i-PrOH), 1.0 mL min−1, 205 nm, tR (major) = 12.8 min, tR
(minor) = 21.7 min, 85:15 d.r.
(S)-4-Hydroxy-2,6-dimethyl-2,3-dihydro-1H-indene-2-car-
boxylic acid (45).14 To 44 (931 mg, 2.59 mmol) was added glacial
acetic acid (8 mL) and 48% aqueous hydrobromic acid (40 mL). The
reaction mixture was refluxed for 2 h. After this period, the reaction
was diluted with water (50 mL) and extracted with DCM (3 × 50
mL). The combined organic layers were dried over MgSO4, filtered
and concentrated under reduced pressure. Two portions of toluene
(10 mL) were added and evaporated to remove the last traces of
AcOH. The crude material was purified by flash chromatography
using cyclohexane/EtOAc (6:4) affording 45 (491 mg, 2.38 mmol,
92%) as a light yellow solid. Then the product was enantioenriched by
recrystallization as follows: the purified product was solubilized under
heating in a mixture of CHCl3 and cyclohexane (3:1) (proportion 40
mg/mL). The solution was then stored at room temperature for 4
days for crystallization. After separation, nearly racemic crystals (187
mg, 0.908 mmol, 35%) and concentrated enantioenriched mother
liquor (304 mg, 1.47 mmol, 57%) were engaged in the next step to
measure the enantiomeric ratio by HPLC using a chiral stationary
phase. Racemic material was prepared using the same procedure from
racemic 39 (890 mg, 3.80 mmol), glacial acetic acid (12 mL) and 48%
aqueous hydrobromic acid (58 mL) to yield racemic 45 (682 mg, 3.31
mmol, 87%): Rf 0.25 (60:40 PE/AcOEt);
1H NMR (500 MHz,
DMSO-d6) δ 12.24 (brs, 1H), 9.03 (brs, 1H), 6.45 (s, 1H), 6.39 (s,
1H), 3.27 (d, J = 16.3 Hz, 1H), 3.16 (d, J = 16.3 Hz, 1H), 2.60 (d, J =
16.3 Hz, 1H), 2.63 (d, J = 16.3 Hz, 1H), 2.16 (s, 3H), 1.25 (s, 3H);
13C{1H} NMR (126 MHz, DMSO-d6) δ 178.7, 153.3, 143.2, 136.9,
123.9, 116.0, 113.7, 48.8, 43.8, 40.2, 25.1, 21.0; IR νmax/cm
−1 (neat)
3282, 2924, 1696, 1306, 1121, 835 cm−1; HRMS (ESI) m/z [M +
Na]+ calcd for C12H14NaO3 229.0835, found 229.0838; [α]D
23 + 6.9°
(c = 0.57, CHCl3).
Methyl (S)-4-(allyloxy)-2,6-dimethyl-2,3-dihydro-1H-in-
dene-2-carboxylate (45a).14 45 (304 mg, 1.47 mmol) was
dissolved in DMF (12 mL) and KHCO3 (442 g, 4.41 mmol, 3
equiv) was added. The suspension was stirred for 10 min at room
temperature, and then iodomethane (0.28 mL, 4.41 mmol, 3 equiv)
was added. The mixture was stirred at 40 °C until total consumption
of starting material (approximately 3 h). To remove the excess of
iodomethane, the reaction was heated to 65 °C under a flow of argon
for 15 min. After this period, the temperature was lowered to 40 °C,
then NaH (106 mg, 4.41 mmol, 3 equiv) and allyl bromide (0.40 mL,
4.41 mmol, 3 equiv) were added successively carefully. The reaction
mixture was stirred for 30 min and then cooled with an ice bath, and
then water (30 mL) was added. The reaction was extracted three
times with DCM (15 mL); the combined organic phases were dried
over MgSO4, filtered and concentrated under reduced pressure. The
crude material was purified by flash column chromatography using
cyclohexane/EtOAc (9:1) leading to 45a as a light yellow oil (315
mg, 1.21 mmol, 82%). Racemic material was prepared using the same
procedure from racemic 45 (650 mg, 3.15 mmol), KHCO3 (947 mg,
9.45 mmol, 3 equiv), iodomethane (0.59 mL, 9.45 mmol, 3 equiv),
NaH (227 mg, 9.45 mmol, 3 equiv) and allyl bromide (0.82 mL, 9.45
mmol, 3 equiv) to yield racemic 45a (730 mg, 2.80 mmol, 89%): Rf
0.25 (95:5 PE/AcOEt); 1H NMR (500 MHz, CDCl3) δ 6.65 (s, 1H),
6.50 (s, 1H), 6.06 (ddt, J = 17.2, 10.5, 5.1 Hz, 1H), 5.42 (dq, J = 17.2,
1.6 Hz, 1H), 5.27 (dq, J = 10.5, 1.6 Hz, 1H), 4.53 (dt, J = 5.1, 1.6 Hz,
2H), 3.72 (s, 3H), 3.47 (d, J = 16.1 Hz, 1H), 3.37 (d, J = 16.1 Hz,
1H), 2.84 (d, J = 16.1 Hz, 1H), 2.77 (d, J = 16.1 Hz, 1H), 2.32 (s,
3H), 1.37 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.3, 155.1,
143.3, 138.1, 133.7, 126.3, 117.9, 117.1, 110.6, 68.7, 52.2, 49.5, 44.4,
40.8, 25.6, 21.8; IR νmax/cm
−1 (neat) 2926, 1730, 1591, 1315, 1112,
1073, 829 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C16H20NaO3
283.1305, found 283.1307; HPLC separation: Chiralpak IA; 99:1 (n-
heptane/i-PrOH), 1.0 mL min−1, 208 nm, tR (major) = 5.0 min, tR
(minor) = 6.1 min, 96:4 e.r.; [α]D
23 + 5.2° (c = 1.00, CHCl3).
Methyl (S)-5-allyl-4-hydroxy-2,6-dimethyl-2,3-dihydro-1H-
indene-2-carboxylate (40).14 A sealed tube charged with 45a
(204 mg, 0.784 mmol) and N,N-diethylaniline (3 mL) was heated
under stirring at 200 °C for 24 h. After this period, the reaction was
poured into 1 M HCl (30 mL) and extracted three times with DCM
(30 mL). The combined organic layers were dried over MgSO4,
filtered and concentrated under reduced pressure. The crude material
was purified by flash chromatography using cyclohexane/EtOAc (9:1)
leading to 40 (163 mg, 0.626 mmol, 80%) as a yellow oil which
solidified on standing. Racemic material was prepared using the same
procedure from racemic 45a (700 mg, 2.69 mmol) to yield racemic
40 (616 mg, 2.37 mmol, 88%): Rf 0.25 (85:15 PE/AcOEt); mp 65−
67 °C; 1H NMR (500 MHz, CDCl3) δ 6.65 (s, 1H), 5.95 (ddt, J =
17.1, 10.2, 5.9 Hz, 1H), 5.07 (dq, J = 10.2, 1.8 Hz, 1H), 5.05 (dq, J =
17.1, 1.8 Hz, 1H), 4.79 (s, 1H), 3.72 (s, 3H), 3.44 (d, J = 16.0 Hz,
1H), 3.40 (dt, J = 5.9, 1.8 Hz, 2H), 3.37 (d, J = 15.6 Hz, 1H), 2.77 (d,
J = 16.0 Hz, 1H), 2.76 (d, J = 15.6 Hz, 1H), 2.26 (s, 3H), 1.38 (s,
3H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.2, 150.6, 1401.0,
136.8, 136.0, 124.6, 121.6, 118.9, 115.5, 52.3, 49.8, 44.3, 40.3, 30.8,
25.6, 20.0; IR νmax/cm
−1 (neat) 3464, 2929, 1712, 1195, 1113, 909
cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C16H20NaO3 283.1305,
found 283.1308; HPLC separation: Chiralpak IA; 97:3 (n-heptane/i-
PrOH), 1.0 mL min−1, 208 nm, tR (minor) = 14.6 min, tR (major) =
16.8 min, 96:4 e.r.; [α]D
23 + 10.8° (c = 1.00, CHCl3).
Methyl (S)-4-hydroxy-5-(2-hydroxyethyl)-2,6-dimethyl-2,3-
dihydro-1H-indene-2-carboxylate (46).14 In a round-bottom
flask containing a stirred biphasic solution of 40 (102 mg, 0.392
mmol) in EtOAc (10 mL) and water (5 mL) was added OsO4 (5.0
mg, 19.6 μmol, 5 mol %). After 5 min, NaIO4 (210 mg, 0.98 mmol,
2.5 equiv) was added in two portions separated by 5 min. The
solution was vigorously stirred for 3 h at room temperature. The
layers were separated and the aqueous phase was extracted twice with
ethyl acetate (6 mL). The combined organic layers were dried over
MgSO4, filtered and concentrated under reduced pressure. The crude
material was diluted in MeOH (10 mL) and cooled to 0 °C. After
this, NaBH4 (44.5 mg, 1.18 mmol, 3 equiv) was added and the
reaction was allowed to reach room temperature. After 30 min, H2O
was added and the reaction was extracted three times with ethyl
acetate (6 mL). The combined organic phases were dried over
MgSO4, filtered and concentrated under reduced pressure. The crude
material was purified by flash chromatography using cyclohexane/
EtOAc (6:4) leading to 46 (78 mg, 0.295 mmol, 75%) as a light
yellow oil. Racemic material was prepared using the same procedure
from racemic 40 (257 mg, 0.987 mmol), OsO4 (12.5 mg, 49.4 μmol, 5
mol %), NaIO4 (528 mg, 2.47 mmol, 2.5 equiv) and NaBH4 (112 mg,
2.96 mmol, 3 equiv) to yield racemic 46 (195 mg, 0.737 mmol, 75%):
Rf 0.26 (70:30 PE/AcOEt);
1H NMR (500 MHz, CDCl3) δ 6.63 (s,
1H), 3.95−3.86 (m, 2H), 3.71 (s, 3H), 3.42 (d, J = 16.0 Hz, 1H),
3.37 (d, J = 16.0 Hz, 1H), 2.88 (dd, J = 6.4, 4.6 Hz, 2H), 2.82 (d, J =
16.0 Hz, 1H), 2.75 (d, J = 16.0 Hz, 1H), 2.24 (s, 3H), 1.36 (s, 3H);
13C{1H} NMR (126 MHz, CDCl3) δ 178.6, 151.9, 141.3, 136.1,
126.2, 123.1, 118.7, 64.0, 52.2, 49.6, 44.3, 40.9, 29.4, 25.6, 20.3; IR
νmax/cm
−1 (neat) 3313, 2924, 1722, 1188, 1110, 905 cm−1; HRMS
(ESI) m/z [M + Na]+ calcd for C15H20NaO4 287.1254, found
287.1256; [α]D
23 + 1.5° (c = 1.00, CHCl3).
(S)-(+)-Puraquinonic acid (4)..2,6,7,14 Title compound was made
following a procedure of Yakura.26 In a round-bottom flask equipped
with a condenser, 46 (66 mg, 0.25 mmol) and LiOH (157 mg, 3.75
mmol, 15 equiv) in 1,4-dioxane/H2O (1:1, 6 mL) were refluxed for
1.5 h. After this period, the mixture was acidified with 1 M HCl and
extracted three times with EtOAc (15 mL). The combined organic
layers were dried over MgSO4, filtered and concentrated under
reduced pressure. The crude material was diluted in a mixture of
2,2,2-trifluoroethanol/H2O (1:2, 3 mL). Then Oxone (305 mg, 0.992
mmol, 4 equiv) and 4-iodophenoxyacetic acid (7.0 mg, 24.8 μmol, 10
mol %) were added at room temperature. The reaction mixture was
stirred until total consumption of starting material (approximately 1
h), then EtOAc and water were added (5 mL each). The layers were
separated and the aqueous layer was extracted with EtOAc. The
combined organic layers were dried over MgSO4, filtered and
concentrated under reduced pressure. The crude material was purified
by flash chromatography using DCM/MeOH (93:7) leading to (S)-
(+)-puraquinonic acid (4) (54.0 mg, 0.204 mmol, 82% over two
steps) as a yellow oil. Racemic material was prepared using the same
procedure from racemic 46 (29.2 mg, 0.110 mmol), LiOH (39.7 mg,
1.66 mmol, 15 equiv), Oxone (135.8 mg, 0.442 mmol, 4 equiv) and 4-
iodophenoxyacetic acid (3.1 mg, 11.0 μmol, 10 mol %) to yield
racemic puraquinonic acid (4) (25.1 mg, 0.095 mmol, 86%): Rf 0.12
(95:5 DCM/MeOH); 1H NMR (500 MHz, CDCl3) δ 3.76 (t, J = 6.4
Hz, 2H), 3.41−3.34 (m, 2H), 2.79 (t, J = 6.4 Hz, 2H), 2.77−2.71 (m,
2H), 2.07 (s, 3H), 1.42 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ
186.4, 185.9, 181.7, 145.9, 145.5, 143.0, 141.5, 61.6, 47.1, 42.5, 42.4,
30.0, 25.8, 12.4; IR νmax/cm
−1 (neat) 3394, 2925, 1706, 1221, 1172,
1103, 914 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C14H16NaO5
287.0890, found 287.0891; [α]D
23 + 1.4° (c = 0.50, CHCl3) {lit.
2 [α]D
22
− 2.2° (c = 0.55, CHCl3) (R)-ent}.
(S)-(+)-Deliquinone (5)..3,14,15 In a round-bottom flask contain-
ing a stirred biphasic solution of 40 (114 mg, 0.438 mmol) in EtOAc
(14 mL) and water (7 mL) was added OsO4 (5.57 mg, 21.9 μmol, 5
mol %). After 5 min, NaIO4 (234 mg, 1.10 mmol, 2.5 equiv) was
added in two portions separated by 5 min. The solution was
vigorously stirred for 3 h at room temperature. The layers were
separated and the aqueous layer was extracted twice with EtOAc (8
mL). The combined organic layers were dried over MgSO4, filtered
and concentrated under reduced pressure. The crude material was
diluted in dry THF (10 mL) and cooled to 0 °C. After this, LiAlH4
(49.9 mg, 1.31 mmol, 3 equiv) was added and the reaction was
allowed to reach room temperature. After 1 h, H2O was added and
the reaction was extracted three times with ethyl acetate (8 mL). The
combined organic phases were dried over MgSO4, filtered and
concentrated under reduced pressure. Then, the title compound was
made following a procedure of Yakura.25 The crude material was
diluted in a mixture of 2,2,2-trifluoroethanol/H2O (1:2, 9 mL). Then
Oxone (541 mg, 1.76 mmol, 4 equiv) and 4-iodophenoxyacetic acid
(12.2 mg, 44.0 μmol, 10 mol %) were added at room temperature.
The reaction mixture was stirred until total consumption of the
starting material (approximately 1 h), and then EtOAc and water were
added (10 mL each). The layers were separated and the aqueous layer
was extracted with EtOAc. The combined organic layers were dried
over MgSO4, filtered and concentrated under reduced pressure. The
crude material was purified by flash chromatography using DCM/
MeOH (93:7) leading to (S)-(+)-deliquinone (5) (62.7 mg, 0.276
mmol, 62% over two steps) as a yellow oil. Racemic material was
prepared using the same procedure from racemic 40 (220 mg, 0.845
mmol), OsO4 (11.1 mg, 43.7 μmol, 5 mol %), NaIO4 (450 mg, 2.10
mmol, 2.5 equiv), LiAlH4 (98.0 mg, 2.58 mmol, 3 equiv), Oxone
(1,04 g, 3.38 mmol, 4 equiv) and 4-iodophenoxyacetic acid (22.1 mg,
84.5 μmol, 10 mol %) to yield racemic deliquinone (5) (153 mg,
0.647 mmol, 76%): Rf 0.28 (95:5 DCM/MeOH);
1H NMR (500
MHz, CDCl3) δ 3.74 (t, J = 6.5 Hz, 2H), 3.49 (s, 2H), 2.87−2.80 (m,
2H), 2.78 (t, J = 6.5 Hz, 2H), 2.53−2.47 (m, 2H), 2.06 (s, 3H), 1.75
(brs, 1H), 1.69 (brs, 1H), 1.16 (s, 3H); 13C{1H} NMR (126 MHz,
CDCl3) δ 187.0, 186.4, 147.2, 146.8, 142.8, 141.4, 70.2, 61.7, 43.0,
40.8, 40.7, 30.1, 25.0, 12.3; IR νmax/cm
−1 (neat) 3395, 2925, 1644,
1249, 1033 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for
C14H18NaO4 273.1097, found 273.1095; [α]D
23 + 0.9° (c = 1.00,
CHCl3) {lit.
3 [α]D
22 − 0.5° (c = 0.6, CHCl3) (R)-ent}.
Methyl (S)-5-allyl-2,6-dimethyl-4-(((trifluoromethyl)-
sulfonyl)oxy)-2,3-dihydro-1H-indene-2-carboxylate (40a).14
To a solution of 40 (58.1 mg, 0.223 mmol) in DCM (1.2 mL),
pyridine (54 μL, 0.669 mmol, 3 equiv) and trifluoromethanesulfonic
anhydride (41 μL, 0.245 mmol, 1.1 equiv) were added. The reaction
mixture was stirred at room temperature during 6 h. The reaction was
then concentrated and purified by flash column chromatography to
yield 40a (80.9 mg, 0.206 mmol, 93%) as a colorless liquid. Racemic
material was prepared using the same procedure from racemic 40 (50
mg, 0.192 mmol), pyridine (47 μL, 0.576 mmol, 3 equiv) and
trifluoromethanesulfonic anhydride (36 μL, 0.211 mmol, 1.1 equiv) to
yield racemic 40a (87.1 mg, 0.167 mmol, 87%): Rf 0.25 (95:5 PE/
AcOEt); 1H NMR (500 MHz, CDCl3) δ 7.03 (s, 1H), 5.83 (ddt, J =
17.1, 10.1, 5.8 Hz, 1H), 5.04 (dq, J = 10.1, 1.7 Hz, 1H), 4.89 (dq, J =
17.1, 1.7 Hz, 1H), 3.72 (s, 3H), 3.54 (d, J = 16.3 Hz, 1H), 3.49 (d, J =
16.1 Hz, 1H), 3.45 (dt, J = 5.8, 1.7 Hz, 2H), 2.95 (d, J = 16.3 Hz,
1H), 2.82 (d, J = 16.1 Hz, 1H), 2.30 (s, 2H), 1.37 (s, 3H); 13C{1H}
NMR (126 MHz, CDCl3) δ 177.3, 144.3, 142.9, 139.0, 134.4, 132.0,
129.2, 126.7, 118.7 (q, J = 319.8 Hz), 116.0, 52.4, 50.1, 44.1, 41.9,
31.2, 25.0, 19.9; 19F{1H} NMR (376 MHz, CDCl3) δ −73.8; IR νmax/
cm−1 (neat) 2955, 1735, 1405, 1206, 1137, 817 cm−1; HRMS (ESI)
m/z [M + Na]+ calcd for C17H19F3NaO5S 415.0798, found 415.0795;
[α]D
23 + 4.0° (c = 1.09, CHCl3).
Methyl (S)-5-allyl-2,4,6-trimethyl-2,3-dihydro-1H-indene-2-
carboxylate (42).14 Title compound was made following a
procedure of Woodward.27 In an oven dry catalysis tube, 40a (80
mg, 0.204 mmol) was introduced. Then the tube was transferred in a
glovebox, and [Pd2dba3·CHCl3] (5.3 mg, 5.1 μmol, 2.5 mol %) and
XPhos (5.0 mg, 10.2 μmol, 5 mol %) were introduced, and the tube
was closed with a septum. Outside of the glovebox, THF (2.5 mL)
and DABAL-Me3 (41.8 mg, 0.163 mmol, 0.8 equiv, as a solution in 0.8
mL of THF) were added. The septum was rapidly exchanged for a
screw cap. The tube was then introduced in a 75 °C preheated
aluminum heating block and stirred at this temperature for 4 h. After
this period the reaction was cooled to room temperature, quenched
with 2 M HCl (2 mL), and extracted three times with diethyl ether (3
mL). The combined organic layers were dried over MgSO4, filtered
and concentrated under reduced pressure. The crude material was
purified by flash column chromatography to yield 42 as a colorless
liquid (51.7 mg, 0.200 mmol, 98%). Racemic material was prepared
using the same procedure from racemic 40a (50.2 mg, 0.128 mmol),
[Pd2dba3·CHCl3] (3.3 mg, 3.2 μmol, 2.5 mol %), XPhos (3.2 mg, 6.4
μmol, 5 mol %) and DABAL-Me3 (26.3 mg, 0.102 mmol, 0.8 equiv)
to yield racemic 42 (32.4 mg, 0.167 mmol, 98%): Rf 0.33 (95:5 PE/
AcOEt); 1H NMR (500 MHz, CDCl3) δ 6.88 (s, 1H), 5.88 (ddt, J =
17.1, 10.1, 5.7 Hz, 1H), 4.99 (dq, J = 10.1, 1.8 Hz, 1H), 4.88 (dq, J =
17.1, 1.8 Hz, 1H), 3.72 (s, 3H), 3.46 (d, J = 15.9 Hz, 1H), 3.40 (d, J =
15.9 Hz, 1H), 3.38 (dt, J = 5.7, 1.8 Hz, 3H), 2.79 (d, J = 15.9 Hz,
1H), 2.78 (d, J = 15.9 Hz, 1H), 2.27 (s, 3H), 2.18 (s, 3H), 1.37 (s,
3H); 13C{1H} NMR (126 MHz, CDCl3) δ 178.5, 138.8, 138.3, 135.8,
135.3, 134.3, 132.7, 124.0, 114.9, 52.2, 49.1, 44.3, 43.7, 33.7, 25.8,
20.3, 16.0; IR νmax/cm
−1 (neat) 2931, 1732, 1208, 1112, 911 cm−1;
HRMS (ESI) m/z [M + Na]+ calcd for C17H22NaO2 281.1512, found
281.1508; [α]D
23 + 9.4° (c = 1.05, CHCl3).
(S)-(+)-Russujaponol F (6)..4,14 In a round-bottom flask
containing a stirred biphasic solution of 42 (51.7 mg, 0.200 mmol)
in EtOAc (4 mL) and water (2 mL) was added OsO4 (2.5 mg, 10.0
μmol, 5 mol %). After 5 min, NaIO4 (107 mg, 0.500 mmol, 2.5 equiv)
was added in two portions separated by 5 min. The solution was
vigorously stirred for 3 h at room temperature. The layers were
separated and the aqueous layer was extracted twice with EtOAc (5
mL). The combined organic layers were dried over MgSO4, filtered
and concentrated under reduced pressure. The crude material was
diluted in dry THF (5 mL) and cooled to 0 °C. After this, LiAlH4
(22.8 mg, 0.600 mmol, 3 equiv) was added and the reaction was
allowed to reach room temperature overnight. After this period, H2O
was added and the reaction was extracted three times with ethyl
acetate (5 mL). The combined organic phases were dried over
MgSO4, filtered and concentrated under reduced pressure. The crude
material was purified by flash column chromatography to yield (S)-
(+)-russujaponol F (6) as a colorless oil (39.8 mg, 0.170 mmol, 85%).
Racemic material was prepared using the same procedure from
racemic 42 (20.5 mg, 0.079 mmol), OsO4 (1.0 mg, 4.0 μmol, 5 mol
%), NaIO4 (42.5 mg, 0.199 mmol, 2.5 equiv) and LiAlH4 (9.1 mg,
0.238 mmol, 3 equiv) to yield racemic russujaponol F (6) (16.2 mg,
0.069 mmol, 87%): Rf 0.23 (50:50 DCM/MeOH);
1H NMR (400
MHz, C5D5N) δ 6.90 (s, 1H), 5.76 (brs, 2H), 3.99 (t, J = 7.6 Hz,
2H), 3.75 (s, 2H), 3.18 (d, J = 15.9 Hz, 1H), 3.15 (t, J = 7.6 Hz, 2H),
3.09 (d, J = 15.8 Hz, 1H), 2.71 (d, J = 15.8 Hz, 1H), 2.60 (d, J = 15.9
Hz, 1H), 2.37 (s, 3H), 2.24 (s, 3H), 1.35 (s, 3H); 13C{1H} NMR
(126 MHz, C5D5N) δ 140.9, 140.7, 135.3, 134.1, 133.3, 125.0, 70.3,
62.0, 45.4, 43.9, 43.1, 34.5, 25.6, 20.9, 16.5; 1H NMR (400 MHz,
CDCl3) δ 6.86 (s, 1H), 3.74 (t, J = 7.5 Hz, 2H), 3.52 (s, 2H), 2.95 (t,
J = 7.5 Hz, 2H), 2.88 (d, J = 16.0 Hz, 1H), 2.84 (d, J = 16.0 Hz, 1H),
2.63 (d, J = 16.0 Hz, 1H), 2.59 (d, J = 16.0 Hz, 1H), 2.32 (s, 3H),
2.22 (s, 3H), 1.18 (s, 3H); 13C{1H} NMR (126 MHz, CDCl3) δ
140.3, 139.8, 135.3, 133.2, 132.3, 124.4, 71.1, 62.1, 44.3, 43.1, 42.4,
32.9, 24.6, 20.5, 16.2; IR νmax/cm
−1 (neat) 3313, 2920, 2867, 1460,
1037 cm−1; HRMS (ESI) m/z [M + Na]+ calcd for C15H22NaO2
257.1512, found 257.1514; [α]D
23 + 1.0° (c = 1.07, CHCl3); [α]D23 +
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